Group items matching

in title, tags, annotations or url

Aspire Pharma Limited has solidified its position as a leading specialty generics enterprise by adding leuprorelin acetate as a branded generic to its oncology portfolio. Leuprorelin acetate is hormone therapy recommended for patients with high-risk localised, locally advanced, and metastatic prostate cancer, serving as an alternative to surgical castration for locally advanced cases. Used as an alternative to surgical castration for locally advanced prostate cancer, a pre-filled syringe containing 11.25mg of leuprorelin acetate (equivalent to 10.72 mg leuprorelin) is injected subcutaneously into the abdomen. The British pharmaceutical company noted that one of its primary objectives is to seek "new investment opportunities" that brings products and companies into its portfolio, aligning closely with Aspire values and therapeutic focus areas. Prostate cancer is the most common cancer among men in the UK, with an average of over 52,000 men receiving a diagnosis of prostate cancer annually, as per Prostate Cancer UK.

Aspire Pharma Limited has reaffirmed its commitment to combating prostate cancer by adding leuprorelin acetate as a branded generic to its oncology portfolio. This move solidifies Aspire's position as a leading specialty generics enterprise. Leuprorelin acetate is a hormone therapy recommended for patients with high-risk localized, locally advanced, and metastatic prostate cancer. It serves as an alternative to surgical castration for locally advanced cases. A pre-filled syringe containing 11.25mg of leuprorelin acetate (equivalent to 10.72 mg leuprorelin) is injected subcutaneously into the abdomen, providing a vital treatment option for patients.

The government's 200 million dental recovery plan has come under fierce criticism from the opposition party after health minister Dame Andrea Leadsom admitted that there is a "high likelihood" that it will not deliver 2.5 million dental appointments. Published last month, the plan is aimed at ensuring easier and faster access to NHS dental care across England, with up to 1.5 million extra treatments expected to be delivered over the next 12 months. Various new measures were set out to attract new dentists, including increasing dental training places by up to 40 per cent by 2032, as part of the NHS Long Term Workforce Plan. On Tuesday, Leadsom told MPs on the Health and Social Care Committee that the figure was based on NHS modelling of a "complicated set of factors" and there is "quite a high likelihood of not being reliable as is the case with all modelling." Preeti Kaur Gill MP, shadow minister for primary care and public health, expressed shock over the admission by the public health minister that there is uncertainty regarding the plan's ability to deliver on its promises, which she said: "shows the Conservatives are out of ideas and out of time."

The Competition and Markets Authority (CMA) has revoked its initial enforcement order imposed on Pharmacy2U Limited (Pharmacy2U) concerning the acquisition of Metabolic Healthcare Ltd (Lloyds Direct). In the revocation order issued on February 12, the regulator said its decision was "based on the evidence it has received in its assessment of the Merger to date." The CMA served an initial enforcement order under section 72(2) of the Enterprise Act 2002 on Pharmacy2U, P2U Holdings Limited, G Square Capital II L.P., G Square Healthcare Private Equity LLP (collectively, the Acquirer Group) and Lloyds Direct on 28 November 2023. It announced that it was considering "whether it is or may be the case that a relevant merger situation has been created and whether the creation of that situation has resulted or may be expected to result in a substantial lessening of competition in any market or markets in the United Kingdom (UK)."

Britain's antitrust regulator, the Competition and Markets Authority (CMA) on Wednesday announced that it is investigating the acquisition of LloydsDirect by Pharmacy2U last year, and has launched its first phase of the merger inquiry. The completed deal between two of the UK's foremost online pharmacies was announced in a joint statement issued on 9 October, confirming that they would operate as Pharmacy2U. Commenting on the purchase, Kevin Heath, CEO of Pharmacy2U, then said: "Combining the best of both of our businesses, we can provide patients with greater access and convenience." The regulator is considering "whether it is or may be the case that this merger has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services."

Britain's drug regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) on Monday announced that fluoroquinolone antibiotics must only be administered when no other antibiotics are appropriate for use. It elaborated that fluoroquinolones given systemically (by mouth, injection, or inhalation) should only be prescribed "when other recommended antibiotics have failed, will not work due to resistance, or are unsafe to use in an individual patient." Previous regulations on fluoroquinolones stated that this class of antibiotics should not be prescribed for mild to moderate or self-limiting infections, or non-bacterial conditions. Further restrictions have been introduced after receiving reports from patients who have experienced long-lasting or disabling reactions following use of fluoroquinolones, the MHRA revealed. Dr Alison Cave, MHRA Chief Safety Officer, said: "Patient safety is our top priority. We have listened to the experience of patients regarding long-lasting and potentially irreversible adverse reactions following use of fluoroquinolone antibiotics, in some cases prescribed for mild-to-moderate infections.

Pharmacists in the UK are reporting significant shortages of a common antibiotic used to treat whooping cough (pertussis), amid rising cases of this bacterial infection. Dr. Leyla Hannbeck, chief executive of the Independent Pharmacies Association (IPA), told BBC Radio 4's Today programme that clarithromycin, one of the key antibiotics for treating whooping cough in children, is "completely out of stock." Clarithromycin is an antibiotic commonly recommended for babies and infants under the age of 1 month. Dr. Leyla said that as pharmacies cannot get the antibiotic, they are being forced to turn patients away or send them back to their doctors to have their prescriptions changed to azithromycin or other antibiotics for treating whooping cough.

Long appointment wait times, embarrassment, and lack of trust are causing thousands of Brits to avoid visiting doctors, according to new research by Newfoundland Diagnostics. With 1 in 4 individuals resorting to A&E due to the lack of available GP appointments, which adds to the NHS burden, the medical self-testing brand believes that educating the nation on at-home testing can help ease the strain on the health service. The research revealed the top five reasons why Brits avoid visiting doctors for medical testing: Appointments taking too long to book (28 per cent) Embarrassment around their illnesses (15 per cent) Preference for at-home testing (12 per cent) Not having time (10 per cent) Lack of trust in the NHS or their GP (7 per cent) The research team cautioned that delaying care can worsen conditions, resulting in more severe cases that place greater strain on the NHS.

We've all heard of Dry January, but that doesn't mean that the first month of the year is the only one where you can quit the booze for an intermittent period. No, you can do it anytime and often it can be just the push you need to review your relationship with the hard stuff. More and more of us are developing problematic relationships with alcohol, and the likes of addiction are on the rise. Attempting an alcohol detox can be a good way to understand your relationship, although if you are heavily reliant on the substance, it is worth doing it in a controlled and safe environment with professional care. That said, for many of us that isn't the case and giving up for a month can see a wealth of changes in your life. So, what can you expect exactly? Improved Physical Health First and foremost, your physical health will improve as a result. Alcohol is known for its empty calories and sugar. It's why many of us develop beer bellys and gain weight when we drink regularly. Ultimately, by cutting those calories, you'll find it much easier to shed weight and the results can happen relatively quickly. What's more, as alcohol slows down metabolism and can often lead to poor food choices like takeaways, eliminating it makes it much easier to manage your weight.

Science and technology help for the better lifestyles. It has transformed human life more efficiently. We must agree with this as not even a single field is there where we don't use technology. But still, research is ongoing for finding some new technologies by using previously available knowledge and techniques.

It may also be useful in case of organ absence. Also, we need to get the fully functional body tissue which is easy to transplant.

A professional medical billing service will always comply with HIPAA regulations. In case of any negligence in this sector, physicians and billing companies may come under the attack of penalties and a bad reputation.

India is witnessing a rise in confirmed Covid-19 cases. Credit: CDC on Unsplash Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

P3Care, being a proud part of the healthcare industry, always tries to educate its audience with the latest and authenticated information. Today, we are bringing up the topic of how to protect everyone around us.

However, with a much-improved situation now, the government encourages private practices and clinics to resume their normal operations. They are to continue with their postponed non-emergency treatments and carry out in-person patient visits as we speak.

America should adopt smarter ways to counter COVID-19 as it reopens for patients and clinicians. In the meanwhile, CMS has come up with a guide for patients and beneficiaries as they decide to visit providers for in-person care.

Home remedies for leg pain at night. It is very important to consult a specialist in case the condition is more serious. However, these home remedies can help us alleviate and improve pain.

The last few months have been tough for the healthcare industry. All stakeholders were trying desperately to assist each other and save resources for COVID-19 response. Of course, meanwhile, CMS also took necessary measures to unburden some of the clinicians' load.

Where physicians have already burned out with COVID -19 cases, the administrative burden of QPP MIPS 2020 was additional pressure. The dynamics have changed. The contact points that were easily accessible before are now operational via online mediums.

COVID-19 has struck everything. From people to the economy, everything is suffering, and the death toll is increasing day by day. While some countries have managed to restrict the risk like China, some are still struggling. The symptoms of this infection are cough, flu, fever, and fatal respiratory issues. Although, this virus is serious but not every COVID positive person ends up in the hospital, generally, the intense or worse cases require hospitalization.

The world at large holds its breath as life is about to normalize. It is going to take more than just the will to reopen amidst COVID-19, especially the schools. What we need to do is act upon a persistent, consistent, and watchful approach. Because one small mistake can cost us precious lives.

Every country is trying to combat with COVID-19 according to its resources. Politicians, doctors, scientists and economy experts are trying to find a perfect mix which can work well in this situation. Some countries are acting smartly. Along with these efforts, they are also observing the conditions of other countries to improvise their policies.